Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 232-235-1 | CAS number: 7790-98-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Toxicity to reproduction
Administrative data
- Endpoint:
- two-generation reproductive toxicity
- Remarks:
- based on test type (migrated information)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- December 1997 - April 1999
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Sufficiently compliant to GLP. Wrong OECD guideline quoted. Occasional inconsistence between data, calculations, comments and conclusions (e.g. drinking water perchlorate concentrations wrongly stated to be within +-10%; errors in gestation index calculations). The top-dose was not based on dose-limiting toxicity but on antithyroid effects, limiting the sensitivity of the study for classification for effects on Fertility. Some investigations are lacking or are not performed according to the most sensitive method. Thyroid adenomas not reported in the report conclusion.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 999
- Report date:
- 1999
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.3800 (Reproduction and Fertility Effects)
- Deviations:
- not specified
- Remarks:
- not examined; see deviations to OECD method
- Qualifier:
- according to guideline
- Guideline:
- other: EPA Pesticides Assessment Guidelines. Subdivision F
- Deviations:
- not specified
- Remarks:
- not examined; see deviations to OECD method
- Qualifier:
- according to guideline
- Guideline:
- other: JMAFF. 59 NohSan No. 4200
- Deviations:
- not specified
- Remarks:
- not examined; see deviations to OECD method
- Qualifier:
- according to guideline
- Guideline:
- other: OECD Guideline 414 (Prenatal Developmental Toxicity Study)
- Deviations:
- not applicable
- Remarks:
- This guideline is not applicable to this test (mistake in report)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 416 (Two-Generation Reproduction Toxicity Study)
- Version / remarks:
- NB: guideline not cited in report.
- Deviations:
- yes
- Remarks:
- Testes stained with hematoxylin/eosin. Uterus+coagulating glands not weighed. No histology of primordial follicles. Paternal/maternal NOAELs instd. of parental/offspring NOAELs (set by RSS author). T°C: 18-26 instd. of 19-25.
- GLP compliance:
- yes
- Remarks:
- No laboratory compliance certificate. No test item analytical certificate. Perchlorate concentrations were most often outside the range validated for stability at the highest dose.
- Limit test:
- no
Test material
- Reference substance name:
- Ammonium perchlorate
- EC Number:
- 232-235-1
- EC Name:
- Ammonium perchlorate
- Cas Number:
- 7790-98-9
- Molecular formula:
- ClHO4.H3N
- IUPAC Name:
- ammonium perchlorate
- Details on test material:
- - Substance type: MCP
- Physical state: solid powder
- Nominal purity: not indicated (NB: 99.8% based on other studies on the same batch)
- Lot/batch No.: 03907LF
- Expiration date of the lot/batch: not indicated
- Stability under test conditions: not indicated but stability verified in drinking water
- Storage condition of test material: at room temperature
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories
- Age at study initiation: (P) more than 5 wks; (F1) 3 wks (once weaned)
- Weight at study initiation: (P) Males: 112-144 g; Females: 121-145 g; (F1) means: 43-46 g (once weaned)
- Fasting period before study: no
- Housing: cages not detailed, individual except during mating and lactation (females)
- Diet (e.g. ad libitum): PMI Certified Rodent Diet, ad libitum
- Water (e.g. ad libitum): reverse osmosis water, ad libitum
- Acclimation period: 6 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18-26
- Humidity (%): 30-70
- Air changes (per hr): at least 10
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: 1998-01-06 To: 1998-09-16
Administration / exposure
- Route of administration:
- oral: drinking water
- Vehicle:
- water
- Details on exposure:
- VEHICLE
- Nature: reverse osmosis drinking water
- Justification for use and choice of vehicle: high solubility of the test item in water
- Lot/batch no. (if required): not applicable
- Purity: not applicable
- Less than 0.5 mg/L (LOD) of nitrate, a possible interference ion for perchlorate
PREPARATION OF TREATED DRINKING WATER:
- Dilution from a stock solution at 50 mg/mL
- Concentration adapted weekly (using body weight and water consumption) to reach the target dose-levels in mg/kg/day: 0.96-526 µg/mL
- Frequency of preparation: at least once a week (diluted solutions)
- Storage: refrigerated (stock solutions) / not indicated (diluted solutions) - Details on mating procedure:
- - M/F ratio per cage: 1
- Length of cohabitation: 2 weeks
- Proof of pregnancy: vaginal plug or sperm in vaginal smear, referred to as day 0 of pregnancy
- No replacement of males or further mating.
- Verification of same strain and source of both sexes: yes
- After successful mating each pregnant female was caged (how): in a nesting box - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Methods:
- validated ion chromatography method
- LOD for perchlorate and nitrate (interference ion): 0.005 µg/mL
Results:
- at all doses: concentrations within +/- 10% of nominals on 8/9 preparation occasions, except for preparations dated 5 may (up to +49%).
- at 0.05 and 200 µg/mL: stable over 109 days at 21-22°C under light (12h/day) - demonstrated in another study (7.5.1)
Comments:
- For almost all high-dose preparation occasions, the target concentrations were above the maximal concentration demonstrated to be stable (200 µg/mL).
- This validation otherwise adequately covers the study's test item use conditions. - Duration of treatment / exposure:
- P1: 113 to 137 days
F1 adults: 125 to 142 days
(incl. at least 70 days before mating, up to 2-week mating, 3-week gestation, 3-week lactation) - Frequency of treatment:
- Continuous (treated water ad libitum)
- Details on study schedule:
- - F1 parental animals not mated until 70 days of exposure after selected from the F1 litters.
- Selection of parents from F1 generation when pups were weaned/21 days of age.
- Age at mating of the mated animals in the study: at least 15 weeks
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
0.3 mg/kg/day
Basis:
other: nominal dose; time-weighed average achieved dose within +/- 10% of nominal, except during gestation for P1 females (+33%) and F1 females (-33% ), and during lactation of F1 females (+33%)
- Remarks:
- Doses / Concentrations:
3 mg/kg/day
Basis:
other: nominal dose; time-weighed average achieved dose within +/- 10% of nominal, except during gestation for P1 females (+33%) and during lactation of F1 females (+20%)
- Remarks:
- Doses / Concentrations:
30 mg/kg/day
Basis:
other: nominal dose; time-weighed average achieved dose within +/- 10% of nominal, except during gestation for P1 females (+34%) and during exposure of F1 males (-12%) and during lactation of F1 females (+16%)
- No. of animals per sex per dose:
- 30
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: based on a 14-day study with NOAELs of 0.44(M) / 0.12(F) mg/kg/day, on a neurobehavioral study, and on a 90-day study (see 7.5.1)
- Rationale for animal assignment: random - Positive control:
- no
Examinations
- Parental animals: Observations and examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: twice daily for viability
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: daily
BODY WEIGHT: Yes
- Time schedule for examinations: at least weekly throughout study
FOOD CONSUMPTION: Yes
- Time schedule: weekly throughout study
WATER CONSUMPTION AND COMPOUND INTAKE: Yes
- Time schedule for examinations: at least 3 times a week, individually
- Calculated as mg/kg/day from body weight data
THYROID HORMONE LEVELS:
TSH, T3 and T4 in serum at sacrifice after weaning of pups - Oestrous cyclicity (parental animals):
- Assessed daily (vaginal cytology) during 3 weeks before mating, and during mating until evidence of successful mating
- Sperm parameters (parental animals):
- Parameters examined in P/F1 male parental generations:
testis weight, epididymis weight, prostate weight, seminal vesicle weight, spermatid count in testes, enumeration of cauda epididymal sperm reserve, sperm motility, sperm morphology - Litter observations:
- STANDARDISATION OF LITTERS: not indicated, but there were at most 30 rats/sex/dose/offspring generation
PARAMETERS EXAMINED
The following parameters were examined in F1 / F2 offspring:
number and sex of pups, stillbirths, live births, postnatal mortality, presence of gross anomalies, weight gain, physical abnormalities
GROSS EXAMINATION OF DEAD PUPS:
- evaluation of vital status at birth (to identify stillborn pups)
- gross exam. for external and internal abnormalities; possible cause of death was determined for pups born or found dead
THYROID HORMONE LEVELS:
TSH, T3 and T4 in serum at sacrifice of pups after weaning - Postmortem examinations (parental animals):
- SACRIFICE
- Male and female animals: all surviving animals after the last litter of each generation was weaned
GROSS NECROPSY
- Gross necropsy consisted of external and internal examinations including the cervical, thoracic, and abdominal viscera
HISTOPATHOLOGY / ORGAN WEIGHTS
Organs/tissues were prepared for microscopic examination and weighed as required by OECD 416, except for those listed in deviations. - Postmortem examinations (offspring):
- SACRIFICE
- The F1 offspring not selected as parental animals and all F2 offspring were sacrificed at 21 days of age (weaning).
- 3 pups/sex/litter/generation were subjected to postmortem macroscopic and microscopic examination as follows:
GROSS NECROPSY
- Gross necropsy consisted of external and internal examinations including the cervical, thoracic, and abdominal viscera
HISTOPATHOLOGY / ORGAN WEIGTHS
Organs/tissues were prepared for microscopic examination and weighed as required by OECD 416, except for those listed in deviations. Thyroids/parathyroids were also weighed. - Statistics:
- See page 54 of report.
- Reproductive indices:
- Mating index:
Number of mated animals
_____________________ x 100
Number of paired animals
Fertility index:
Number of pregnant female partners
_______________________________ x 100
Number of mated pairs
Gestation index:
Number of females with live born pups
________________________________ x 100
Number of pregnant females - Offspring viability indices:
- Live birth index:
Number of live born pups
_____________________ x 100
Number of delivered pups
Viability index on day 4 post-partum:
Number of surviving pups on day 4 post-partum
_______________________________________ x 100
Number of live born pups
Lactation index on day 21 post-partum:
Number of surviving pups on day 21 post-partum
________________________________________ x 100
Number of surviving pups on day 4 post-partum
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- no effects observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Other effects:
- no effects observed
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- no effects observed
- Reproductive function: sperm measures:
- no effects observed
- Reproductive performance:
- no effects observed
Details on results (P0)
P1: One male at 30 mg/kg/day and one female at 3 mg/kg/day sacrificed as the result of an injury.
F1: Three males and one female at 30 mg/kg/day were found dead, the cause was not established but considered unrelated to treatment.
TREATED DRINKING WATER INTAKE (PARENTAL/ADULT ANIMALS)
Reduced in P1 males at 30 mg/kg/day from day 36 until sacrifice. Treatment-related, but not toxicologically relevant (not confirmed with dose-relationship in P1 females, F1 males and F1 females).
THYROID HORMONE LEVELS (PARENTAL/ADULT ANIMALS)
P1: Serum T4 levels significantly decreased and TSH levels significantly increased at 30 mg/kg/day in males. Females unaffected.
T3 significantly increased in males at 0.3, 3.0 but not 30 mg/kg/day: not considered toxicologically relevant (opposite effect when compared to anti-thyroid effects of perchlorate).
F1: Significant increase in TSH (M+F) and decrease in T4 (M) at 30 mg/kg/day: toxicologically relevant. Additionally in males, increased T4 at 0.3 and 3 mg/kg/day: not considered toxicologically relevant (opposite effect when compared to anti-thyroid effects of perchlorate).
ORGAN WEIGHTS (PARENTAL/ADULT ANIMALS)
P1: Significantly higher absolute and/or relative thyroid weights at 3 (M) and 30 (M+F) mg/kg/day.
F1: Significantly higher absolute and relative thyroid weights at 0.3 mg/kg/day in F: not biologically relevant when compared with P1 data; and also at 3 (M+F) and 30 (M+F) mg/kg/day (relevant). Increased spleen weight in males, not toxicologically relevant (not confirmed with dose-relationship and significance in any other generation or sex).
HISTOPATHOLOGY (PARENTAL/ADULT ANIMALS)
P1,F1: dose-related increase in incidence and severity of follicular epithelium hypertrophy and hyperplasia in thyroid, statistically significant from 3 mg/kg/day.
F1: 2 of the 30 male rats developed thyroid follicular cell adenoma by 19 weeks of age, at 30 mg/kg/day. Considered treatment-related by RSS author.
Effect levels (P0)
open allclose all
- Dose descriptor:
- NOAEL
- Remarks:
- Parental toxicity
- Effect level:
- 0.3 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: Relevant antithyroid effects in P1 and F1 adults from 3 mg/kg/day.
- Remarks on result:
- other: Generation: P1 and F1 adults (migrated information)
- Dose descriptor:
- NOAEL
- Remarks:
- Offspring toxicity
- Effect level:
- 0.3 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: Revised by summary author (original report: 3 mg/kg/day). Based on antithyroid effects at higher doses.
- Remarks on result:
- other: Generation: F1 and F2 pups (migrated information)
- Dose descriptor:
- NOAEL
- Remarks:
- Reproduction toxicity
- Effect level:
- >= 30 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: Absence of effects towards reproduction at up to the maximal tested dose.
- Remarks on result:
- other: Generation: all generations (migrated information)
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- no effects observed
- Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Sexual maturation:
- no effects observed
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Gross pathological findings:
- no effects observed
- Histopathological findings:
- effects observed, treatment-related
Details on results (F1)
F1: Significant reduction in T3 in females at 30 mg/kg/day: toxicologically relevant. Reduction in TSH and increase in T4 at 0.3 and/or 3.0 but not 30 mg/kg/day in males, not considered toxicologically relevant (opposite effect when compared to anti-thyroid effects of perchlorate).
F2: Reduction in T3 levels, although not significant, at 30 mg/kg/day in females.
ORGAN WEIGHTS (OFFSPRING)
F1: Significantly higher absolute thyroid weights at 30 mg/kg/day (M+F); relative weights not reported.
F1: In females, higher absolute thyroid weights at 30 (significant) and 3 mg/kg/day (not significant); relative weights not reported.
HISTOPATHOLOGY (OFFSPRING):
F1,F2: dose-related increase in incidence and severity of follicular epithelium hypertrophy and hyperplasia in thyroid, statistically significant from 3 mg/kg/day
Overall reproductive toxicity
- Reproductive effects observed:
- not specified
Any other information on results incl. tables
Effects in adult rats (P1 and F1 adults) exposed to ammonium perchlorate
Sex | Male | Female | ||||||
Dose-level (mg/kg/day) | 0 | 0.3 | 3.0 | 30 | 0 | 0.3 | 3.0 | 30 |
P1 adults at sacrifice (113 -137 days of treatment) | ||||||||
Serum T4 level (µg/dL) | 4.64 | 4.73 | 4.74 | 3.58** | not affected | |||
Serum TSH level (ng/mL) | 1.53 | 1.35 | 1.49 | 3.87** | not affected | |||
Thyroid weight (absolute, mg) | 39 | 41 | 43* | 51** | 24 | 25 | 25 | 30** |
Thyroid weight (% relative to brain) | 1.67 | 1.72 | 1.81 | 2.17** | 1.10 | 1.15 | 1.13 | 1.37** |
Follicle hypertrophy@ | 16/30 | 12/30 | 22/30 | 24/30 | 2/27 | 3/21 | 13/26 | 17/24 |
Follicle hyperplasia@ | 2/30 | 1/30 | 5/30 | 8/30 | 0/27 | 0/21 | 0/26 | 6/24 |
F1 adults at sacrifice (125 -142 days of treatment) | ||||||||
Serum T4 level (µg/dL) | 3.78 | 4.21* | 4.20* | 2.78** | not affected | |||
Serum TSH level (ng/mL) | 2.51 | 2.16 | 2.30 | 5.18** | 1.62 | 1.22 | 1.65 | 2.12* |
Thyroid weight (absolute, mg) | 36 | 41 | 44** | 63** | 22 | 25* | 28** | 33** |
Thyroid weight (% relative to brain) | 1.52 | 1.68 | 1.77** | 2.64** | 1.01 | 1.13* | 1.28** | 1.51** |
Follicle hypertrophy@ | 8/29 | 8/30 | 16/30 | 27/30 | 2/20 | 4/27 | 5/27 | 12/23 |
Follicle hyperplasia@ | 5/29 | 5/30 | 11/30 | 13/30 | 1/20 | 1/27 | 3/27 | 0/23 |
Follicle adenoma (number of rats)@ | 0/29 | 0/30 | 0/30 | 2/30 | 0/20 | 0/27 | 0/27 | 0/23 |
Follicle adenoma (number of adenomas)@ | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 |
statistical difference from controls: *: p<0.05; **: p<0.01; @: peer-review data, no statistical analysis performed
Effects in rat pups (F1 and F2 weaned pups) exposed to ammonium perchlorate
Sex | Male | Female | ||||||
Dose-level (mg/kg/day) | 0 | 0.3 | 3.0 | 30 | 0 | 0.3 | 3.0 | 30 |
F1 pups at weaning | ||||||||
Serum T3 level (ng/dL) | not affected | 106 | 110 | 109 | 97.6* | |||
Thyroid weight (absolute, mg) | 8 | 8 | 8 | 10** | 8 | 9 | 8 | 10** |
Follicle hypertrophy@ | 2/28 | 4/22 | 14/25 | 23/23 | 3/28 | 7/22 | 15/24 | 21/21 |
Follicle hyperplasia@ | 0/28 | 0/22 | 5/25 | 6/23 | 0/28 | 1/22 | 1/24 | 7/21 |
F2 pups at weaning | ||||||||
Serum T3 level (ng/dL) | not affected | 108 | 107 | 108 | 98.8 | |||
Thyroid weight (absolute, mg) | not affected | 8 | 8 | 10 | 9* | |||
Follicle hypertrophy@ | 0/20 | 0/27 | 4/28 | 7/25 | 0/20 | 1/27 | 8/28 | 13/25 |
Follicle hyperplasia@ | 0/20 | 0/27 | 0/28 | 0/25 | 0/20 | 0/27 | 2/28 | 1/25 |
Applicant's summary and conclusion
- Conclusions:
- Parental NOAEL was 0.3 mg/kg/day due to antithyroid effects. However, the parental MTD was above 30 mg/kg/day in the absence of relevant general toxicity (excluding antithyroid effects).
Offspring NOAEL was 0.3 mg/kg/day, as opposed to original report conclusion (3 mg/kg/day), based on anti-thyroid effects at higher doses.
Reproduction NOAEL set at 30 mg/kg/day in the absence of effects on reproductive function at the doses investigated.
The top-dose was not based on dose-limiting toxicity but on antithyroid effects, limiting the sensitivity of the study for classification for effects on Fertility. - Executive summary:
A two-generation study was conducted in rats exposed to ammonium perchlorate at 0, 0.3, 3.0 and 30 mg/kg/day.
- At 30 mg/kg/day, there was a clear antithyroid effect in P1 and F1 adults and F1 and F2 pups: lower serum T3 (female pups) or T4 levels (male adults), higher serum TSH level (adult P1 males, adult F1 males and females), higher absolute and (when determined) relative thyroid weights (in all conditions), minimal to marked thyroid follicle hypertrophy and hyperplasia (in all conditions), thyroid follicle adenomas in two males. There was no general parental toxicity: the maximal tolerated dose was not reached, limiting sensitivity of the study according to summary author. No effects on reproduction and in particular fertility and pup growth were noted.
- At 3 mg/kg/day, no relevant hormonal effects were noted; thyroid weight was affected in adults only; however, incidence and severity of thyroid follicle lesions was increased in all conditions (except possibly in F1 adult females were it was not obvious).
- At 0.3 mg/kg/day, no relevant hormonal effects were noted; thyroid weight was minimally increased in F1 adult females but this was considered not biologically relevant; no relevant effect on thyroid lesions.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.